Primary Tumor Radiotherapy During EGFR-TKI Disease Control Improves Survival of Treatment Naïve Advanced EGFR-Mutant Lung Adenocarcinoma Patients.
Kuo-Hsuan HsuJing-Wen HuangJeng-Sen TsengKuan-Wen ChenYih-Chyang WengSung-Liang YuTsung-Ying YangYen-Hsiang HuangJeremy J W ChenKun-Chieh ChenGee-Chen ChangPublished in: OncoTargets and therapy (2021)
Curative RTPLT can prolong survival in patients with LAD following EGFR-TKI disease control, both involving oligometastasis and polymetastasis. RTPLT within 24 weeks after EGFR-TKI initiation appeared to be more beneficial with tolerable radiation pneumonitis.
Keyphrases
- tyrosine kinase
- epidermal growth factor receptor
- small cell lung cancer
- advanced non small cell lung cancer
- prognostic factors
- newly diagnosed
- ejection fraction
- radiation induced
- squamous cell carcinoma
- radiation therapy
- rheumatoid arthritis
- locally advanced
- smoking cessation
- patient reported
- systemic sclerosis
- gestational age